Biomarker breakthroughs
Search documents
Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth
Businesswire· 2025-11-20 21:15
Nov 20, 2025 4:15 PM Eastern Standard Time Appoints Garret Hampton and Alan Sachs to the Board Appoints William Donnelly as Executive Chair of the Board and Jeffrey Elliott as Lead Independent Director BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation ("Quanterix†or the "Company†) (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced a series of leadership and governance enhancements designed to support the Company's ...